BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 49017)

  • 1. Influence of N2 or O2 on two alkylating agents in Neurospora crassa.
    Seyfried TN
    Mutat Res; 1975 May; 28(2):155-62. PubMed ID: 49017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of N2 on the mutagenic and lethal activities of ICR-170 in Neurospora crassa.
    Whong WZ
    Mutat Res; 1979 May; 60(3):301-12. PubMed ID: 90338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MUTAGENICITY OF A MONOFUNCTIONAL ALKYLATING AGENT DERIVATIVE OF ACRIDINE IN NEUROSPORA.
    BROCKMAN HE; GOBEN W
    Science; 1965 Feb; 147(3659):750-1. PubMed ID: 14242025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxylamine-induced purple mutants (ad-3) in Neurospora crassa. II. Identification of genetic alteration at the molecular level.
    Malling HV
    Hereditas; 1971; 68(2):219-34. PubMed ID: 4281762
    [No Abstract]   [Full Text] [Related]  

  • 5. Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive lethal damage.
    de Serres FJ; Malling HV
    Mutat Res; 1994 Oct; 310(1):15-36. PubMed ID: 7523879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B; de Serres FJ
    J Environ Pathol Toxicol; 1979; 2(4):1109-18. PubMed ID: 156240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
    Ong T; Slade B
    J Toxicol Environ Health; 1978; 4(5-6):815-24. PubMed ID: 153406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azaguanine-resistant mutants induced by several mutagens in a neurospora heterokaryon.
    Hoffmann GR; Malling HV
    Mutat Res; 1975 Mar; 27(3):307-18. PubMed ID: 163959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pH on the mutagenic and killing potencies of ICR-170 in ad-3 tests of Neurospora crassa.
    Whong WZ; Ong T; Brockman HE
    Mutat Res; 1985; 142(1-2):19-22. PubMed ID: 2579330
    [No Abstract]   [Full Text] [Related]  

  • 10. Mutation induction by difunctional alkylating agents in Neurospora crassa.
    Ong TM; Serres FJ
    Genetics; 1975 Jul; 80(3):475-82. PubMed ID: 133852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of Neurospora crassa conidia by singlet molecular oxygen generated by a photosensitized reaction.
    Shimizu M; Egashira T; Takahama U
    J Bacteriol; 1979 May; 138(2):293-6. PubMed ID: 155692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology tests on presumed multilocus deletions in the ad-3 region of Neurospora crassa induced by the acridine mustard ICR-170.
    De Serres FJ; Brockman HE
    Genetics; 1968 Jan; 58(1):79-83. PubMed ID: 5656345
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenic activity and specificity of hydrogen peroxide in the ad-3 forward-mutation test in two-component heterokaryons of Neurospora crassa.
    Han JS
    Mutat Res; 1997 Mar; 374(2):169-84. PubMed ID: 9100841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and classical genetic analyses of his-3 mutants of Neurospora crassa. I. Tests for allelic complementation and specific revertibility.
    Overton LK; Dubins JS; de Serres FJ
    Mutat Res; 1989 Oct; 214(2):267-83. PubMed ID: 2529437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ; Ong TM; Hung CY
    Mutat Res; 1987 Mar; 177(1):61-75. PubMed ID: 2950320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity of neocarzinostatin in Neurospora crassa.
    DeGraff WG
    Mutat Res; 1984 Sep; 128(2):127-35. PubMed ID: 6236365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic evaluation of antischistosomal drugs and their derivatives in Neurospora crassa.
    Ong T; de Serres FJ
    J Toxicol Environ Health; 1975 Nov; 1(2):271-9. PubMed ID: 128637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation induction by rodent liver microsomal metabolities of aflatoxins B1 and G1 in Neurospora crassa.
    Matzinger PK; Ong TM
    Mutat Res; 1976 Oct; 37(1):27-32. PubMed ID: 135208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cytotoxic and mutagenic effects of selected mutagens on excision repair-sufficient and -deficient AD-3 mutants of Neurospora crassa.
    Ong T; Converse JO
    Mutat Res; 1983 Oct; 124(1):61-7. PubMed ID: 6226873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the homokaryotic or heterokaryotic state of the uvs-2 allele in Neurospora crassa on mitomycin C-induced killing and ad-3 mutation.
    Brockman HE; de Serres FJ; Hung CY
    Mutat Res; 1985; 150(1-2):193-202. PubMed ID: 3158811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.